Disease | myeloperoxidase deficiency |
Comorbidity | C0271084|exudative age-related macular degeneration |
Sentences | 1 |
PubMedID- 23695657 | Background: the primary objective of lutega is to determine the long-term effect of a supplementation with fixed combination of lutein, zeaxanthin, omega-3-longchain-polyunsaturated-fatty-acids (o-3-lcpufas) and antioxidants on macular pigment optical density (mpod) in patients with non-exudative age-related macular degeneration (amd). |
Page: 1